Clinical Trial Update: [177Lu]Lu-AKIR001 First-in-human Study [EARLY_Phase 1]

View source ↗

Summary

First-in-human early-phase trial of a Lu-177 radiopharmaceutical, [177Lu]Lu-AKIR001, currently recruiting for various advanced cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Thyroid Carcinoma
• Cervical Cancer
• Head and Neck Cancer
• Non-small Cell Lung Cancer
• Poorly Differentiated Thyroid Carcinoma
• Vulvar Cancer

Drugs mentioned

• [177Lu]Lu-AKIR001

Snippet

Sponsor: Karolinska University Hospital | Conditions: Thyroid Gland Anaplastic Carcinoma, Poorly Differentiated Thyroid Carcinoma | EARLY_Phase 1 | Status: RECRUITING